论文部分内容阅读
目的:探讨舒血宁治疗急性脑缺血的临床疗效。方法:收治急性脑缺血患者200例,随机平分成两组,对照组给予控制血压、血糖和血脂,吸氧、降低颅内压等常规治疗的基础上给予阿司匹林、维脑路通治疗。观察组在对照组的基础上加用舒血宁注射液治疗。结果:观察组总有效率95.0%,高于对照组的76.0%,两组比较,差异有统计学意义(P<0.05),观察组治疗前神经功能评分(25.8±2.9)分,治疗7 d评分(22.2±2.1)分,治疗14 d评分(12.1±1.9)分,对照组上述评分分别为(25.6±2.9)分,(24.8±2.5)分,(16.5±2.3)分,两组组间及组内治疗前后比较,差异有统计学意义(P<0.05)。结论:舒血宁治疗急性脑缺血起效快,神经功能恢复快,疗效显著。
Objective: To investigate the clinical efficacy of Shuxuening in treating acute cerebral ischemia. Methods: A total of 200 patients with acute cerebral ischemia were randomly divided into two groups. The control group was given aspirin and Venoruton on the basis of conventional therapy such as blood pressure control, blood glucose and blood lipid, oxygen inhalation and intracranial pressure reduction. The observation group was treated with Shuxuening injection on the basis of the control group. Results: The total effective rate in the observation group was 95.0%, which was higher than that in the control group (76.0%). There was significant difference between the two groups (P <0.05). The score of neurological function before treatment in the observation group was (25.8 ± 2.9) (22.2 ± 2.1) and 14.1 d (12.1 ± 1.9), respectively. The scores in the control group were (25.6 ± 2.9), (24.8 ± 2.5) and (16.5 ± 2.3) And before and after treatment in the group, the difference was statistically significant (P <0.05). Conclusion: Shuxuening treatment of acute cerebral ischemia rapid onset, rapid recovery of nerve function, a significant effect.